Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piotr Eder

Showing results (71-80 of 114) with videos related to

Pageof 12
Sort By:
International Journal of Molecular Sciences|October 13, 2021
Immunogenetic, Molecular and Microbiotic Determinants of Eosinophilic Esophagitis and Clinical Practice-A New Perspective of an Old DiseaseAlina Kanikowska, Szymon Hryhorowicz, Anna Maria Rychter, et al.
International Journal of Molecular Sciences|July 29, 2020
Is the Retinol-Binding Protein 4 a Possible Risk Factor for Cardiovascular Diseases in Obesity?Anna Maria Rychter, Marzena Skrzypczak-Zielińska, Aleksandra Zielińska, et al.
Polish Archives of Internal Medicine|July 31, 2018
Prevalence of osteoporosis and osteopenia in a population of patients with inflammatory bowel diseases from the Wielkopolska RegionIwona Krela-Kaźmierczak, Michał Michalak, Aleksandra Szymczak-Tomczak, et al.
Przeglad Gastroenterologiczny|January 6, 2017
Diagnostic importance of faecal markers in long-term monitoring of anti-TNF-α therapy in primary responders with Crohn's diseaseLiliana Łykowska-Szuber, Katarzyna Klimczak, Piotr Eder, et al.
Przeglad Gastroenterologiczny|April 26, 2016
Osteoprotegerin, s-RANKL, and selected interleukins in the pathology of bone metabolism in patients with Crohn's diseaseIwona Krela-Kaźmierczak, Ewa Wysocka, Aleksandra Szymczak, et al.
Journal of Clinical Medicine|August 27, 2021
Social Distancing during COVID-19 Pandemic among Inflammatory Bowel Disease PatientsMichał Łodyga, Katarzyna Maciejewska, Piotr Eder, et al.
Frontiers in Immunology|April 10, 2023
Tocilizumab-coated solid lipid nanoparticles loaded with cannabidiol as a novel drug delivery strategy for treating COVID-19: A reviewAleksandra Zielińska, Piotr Eder, Jacek Karczewski, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 7, 2026
Advanced Combination Therapy in Inflammatory Bowel Disease: What Does the Future Hold?Piotr Eder, Adam Fabisiak, Hubert Zatorski, et al.
Archives of Medical Science : AMS|May 24, 2021
Is there a relation between vitamin D, interleukin-17, and bone mineral density in patients with inflammatory bowel disease?Iwona Krela-Kazmierczak, Aleksandra Szymczak-Tomczak, Maciej Tomczak, et al.
Nutrients|August 27, 2021
What Links an Increased Cardiovascular Risk and Inflammatory Bowel Disease? A Narrative ReviewLiliana Łykowska-Szuber, Anna Maria Rychter, Magdalena Dudek, et al.
Pageof 12

Showing results (71-80 of 114) with videos related to

Sort By:
Pageof 12
International Journal of Molecular Sciences|October 13, 2021
Immunogenetic, Molecular and Microbiotic Determinants of Eosinophilic Esophagitis and Clinical Practice-A New Perspective of an Old DiseaseAlina Kanikowska, Szymon Hryhorowicz, Anna Maria Rychter, et al.
International Journal of Molecular Sciences|July 29, 2020
Is the Retinol-Binding Protein 4 a Possible Risk Factor for Cardiovascular Diseases in Obesity?Anna Maria Rychter, Marzena Skrzypczak-Zielińska, Aleksandra Zielińska, et al.
Polish Archives of Internal Medicine|July 31, 2018
Prevalence of osteoporosis and osteopenia in a population of patients with inflammatory bowel diseases from the Wielkopolska RegionIwona Krela-Kaźmierczak, Michał Michalak, Aleksandra Szymczak-Tomczak, et al.
Przeglad Gastroenterologiczny|January 6, 2017
Diagnostic importance of faecal markers in long-term monitoring of anti-TNF-α therapy in primary responders with Crohn's diseaseLiliana Łykowska-Szuber, Katarzyna Klimczak, Piotr Eder, et al.
Przeglad Gastroenterologiczny|April 26, 2016
Osteoprotegerin, s-RANKL, and selected interleukins in the pathology of bone metabolism in patients with Crohn's diseaseIwona Krela-Kaźmierczak, Ewa Wysocka, Aleksandra Szymczak, et al.
Journal of Clinical Medicine|August 27, 2021
Social Distancing during COVID-19 Pandemic among Inflammatory Bowel Disease PatientsMichał Łodyga, Katarzyna Maciejewska, Piotr Eder, et al.
Frontiers in Immunology|April 10, 2023
Tocilizumab-coated solid lipid nanoparticles loaded with cannabidiol as a novel drug delivery strategy for treating COVID-19: A reviewAleksandra Zielińska, Piotr Eder, Jacek Karczewski, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 7, 2026
Advanced Combination Therapy in Inflammatory Bowel Disease: What Does the Future Hold?Piotr Eder, Adam Fabisiak, Hubert Zatorski, et al.
Archives of Medical Science : AMS|May 24, 2021
Is there a relation between vitamin D, interleukin-17, and bone mineral density in patients with inflammatory bowel disease?Iwona Krela-Kazmierczak, Aleksandra Szymczak-Tomczak, Maciej Tomczak, et al.
Nutrients|August 27, 2021
What Links an Increased Cardiovascular Risk and Inflammatory Bowel Disease? A Narrative ReviewLiliana Łykowska-Szuber, Anna Maria Rychter, Magdalena Dudek, et al.
Pageof 12